Today: 1 May 2026
Browse Category

NYSE:ELV 21 October 2025 - 5 January 2026

UnitedHealth stock ticks up after Barclays target hike as UNH earnings near

UnitedHealth stock ticks up after Barclays target hike as UNH earnings near

UnitedHealth shares rose 0.8% to $338.94 in late-morning trading Monday after Barclays raised its price target to $391 and reiterated an Overweight rating. Investors are watching ahead of Jan. 27, when UnitedHealth will report 2025 results and 2026 guidance. Scrutiny remains on medical-cost trends, operational review progress, and ongoing Justice Department investigations into Medicare Advantage billing.
5 January 2026
·····
UnitedHealth stock rises into the weekend — what UNH investors watch before Jan. 27 results

UnitedHealth stock rises into the weekend — what UNH investors watch before Jan. 27 results

UnitedHealth Group shares rose 1.9% to $336.40 Friday, trading 6.9 million shares and closing above key moving averages. The company will report full-year results and its 2026 outlook before the market opens Jan. 27. UnitedHealth remains under Justice Department investigation over billing practices. The stock is well below its 52-week high of $606.36.
5 January 2026
····
Elevance Health (ELV) Stock News Today: ACA Subsidy Deadline Looms, Fitch Affirms A- Rating, and Analysts See Modest Upside (Dec. 12, 2025)

Elevance Health (ELV) Stock News Today: ACA Subsidy Deadline Looms, Fitch Affirms A- Rating, and Analysts See Modest Upside (Dec. 12, 2025)

Elevance Health shares held near $360.52 on Dec. 12 after jumping 5.6% Thursday, breaking above their 200-day moving average. The US Senate failed overnight to extend enhanced ACA subsidies, raising the risk of higher premiums for about 24 million Americans in 2026. Congress is not expected to revisit the issue until January. ELV’s 52-week range spans $273.71 to $458.75.
12 December 2025
Elevance Health (ELV) Stock: December 2025 Outlook After Q3 Earnings Beat, Legal Headwinds and New Analyst Targets

Elevance Health (ELV) Stock: December 2025 Outlook After Q3 Earnings Beat, Legal Headwinds and New Analyst Targets

Elevance Health shares traded near $331 early December 3, about 30% below their 52-week high despite a strong Q3 earnings report. The stock is down 18% over the past year, underperforming the S&P 500. Q3 operating revenue rose 12% to $50.1 billion, with net income up nearly 18% to $1.2 billion. Shares fell 2.5% at the start of December before stabilizing.
3 December 2025
·
Elevance Health Stock Soars on Massive Q3 Earnings Beat – What It Means for Investors

Elevance Health Stock Soars on Massive Q3 Earnings Beat – What It Means for Investors

Elevance Health reported Q3 2025 adjusted earnings of $6.03 per share, beating analyst estimates by over $1. Revenue reached $50.1 billion, up 12% year-over-year and ahead of forecasts. Shares jumped as much as 7% pre-market on Oct. 21 before settling near the prior close. The company reaffirmed its full-year outlook and kept costs slightly below expectations.
21 October 2025
····
1 2

Stock Market Today

  • Top 3 Cryptocurrencies to Hedge Against Rising U.S. Debt and Inflation Risks
    May 1, 2026, 4:37 PM EDT. The U.S. government's interest payments have surged to $970 billion in 2025, surpassing national defense spending and raising concerns of increased money printing or "the big print." This scenario suggests rising inflation, potentially eroding the dollar's value. Fiscal experts project deficits above $2 trillion annually, limiting spending flexibility. Investors increasingly consider inflation-hedging assets. Cryptocurrencies like Bitcoin (BTC), Zcash (ZEC), and tokenized gold through Tether Gold (XAUT) offer protection. Bitcoin's capped supply combats inflation, Zcash provides privacy features, and tokenized gold represents tangible value. Allocating to these assets can help investors prepare for prolonged inflation pressures driven by U.S. fiscal dynamics.

Latest article

Oracle Stock Jumps After Pentagon AI Win, OpenAI Reassurance

Oracle Stock Jumps After Pentagon AI Win, OpenAI Reassurance

1 May 2026
Oracle shares jumped 6.4% to $171.74 after the U.S. War Department cleared the company to deploy AI on classified military networks. The move eased investor concerns over Oracle’s exposure to OpenAI and its costly AI data-center expansion. Trading volume topped 22 million shares in late New York trading.
Zoom Communications Stock Jumps as May 21 Earnings Test Puts AI Plan on Clock

Zoom Communications Stock Jumps as May 21 Earnings Test Puts AI Plan on Clock

1 May 2026
Zoom shares rose 6.6% to $103.60 Friday, trading over 4.7 million shares. The company will report first-quarter fiscal 2027 results on May 21 and hold its virtual annual meeting on June 11, where shareholders will vote on directors, auditor, and executive pay. Fourth-quarter revenue reached $1.247 billion, up 5.3% year-over-year.
GameStop’s $9 Billion Cash Pile Just Put Its Stock Back In Play

GameStop’s $9 Billion Cash Pile Just Put Its Stock Back In Play

1 May 2026
GameStop shares rose to $26.61 Friday in New York, extending gains above the 200-day moving average as investors speculated on CEO Ryan Cohen’s plans for $9 billion in cash and securities. Fiscal fourth-quarter results showed net sales down to $1.104 billion, but operating income climbed to $135.2 million. Collectibles revenue jumped 47.7% year over year, now making up 29.2% of sales.
Go toTop